We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App





Heart MRI Scans Can Enable More Accurate COVID-19 Diagnoses and Target Treatments More Effectively

By HospiMedica International staff writers
Posted on 26 Feb 2021
A new study has shown that some patients who have been discharged from hospital following severe COVID-19 illness have evidence of damage to their heart on MRI scans which can help identify different patterns of injury to enable more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.

In the study, researchers at Imperial College Healthcare (London, UK) studied 148 patients who had been hospitalized with severe COVID-19 and who showed raised levels of a protein called troponin in blood tests. More...
Troponin is released into the blood when the heart is injured and can indicate possible damage. The patients studied had been very unwell, with one in three also having been on a ventilator in intensive care. They found that around half of these patients had evidence of damage to the heart on MRI scans performed, on average, around 10 weeks after discharge. Damage included inflammation of the heart muscle, scarring or death of heart tissue, restricted blood supply to the heart and combinations of all three.

Some patients who are hospitalized with COVID-19 have raised troponin levels during the most critical phase of their illness, which is when the body mounts an exaggerated immune response to the infection. Raised levels can occur when an artery becomes blocked or there is inflammation of the heart, but it can be challenging for clinicians to identify the extent or cause of the damage without imaging. The results also show that, despite being very unwell and having raised troponin levels, around half of the patients studied had no evidence on their scan of damage to their heart.

COVID-19 patients who had abnormal troponin levels had MRI scans of the heart after discharge as part of their normal care and these were compared with those from a control group of patients who had not had COVID-19, as well as with 40 healthy volunteers. The study found that around half of patients had evidence of injury, but also that different patterns occurred, suggesting that the heart may be at risk of different types of injury. The researchers also noted that in some cases MRI scans may be showing evidence of existing damage due to the patients’ underlying conditions. The researchers hope that the findings will provide insight into new ways of preventing injury to the heart in the first place, such as early treatment for blood clots, but also for identifying patients who would benefit from treatments to protect their heart function in the future.

“Raised troponin levels are associated with worse outcomes in COVID-19 patients and it is important to understand more about the extent and potential causes of heart damage,” said Dr. Graham Cole, consultant cardiologist at Imperial College Healthcare, who led the study. “MRI scans help identify different patterns of injury, which may enable us to make more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.”

Related Links:
Imperial College Healthcare


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Thoracolumbar & Sacropelvic System
Ennovate TLSP
New
Critical Care Cart
Avalo
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.